What does DR. HUYSMANS G. - DR. EERDEKENS S. do?

DR. HUYSMANS G. - DR. EERDEKENS S. is a general practice in Wuustwezel. Private Limited, started on 24 February 2003, 1 establishment.

What is the address of DR. HUYSMANS G. - DR. EERDEKENS S.?

The registered office of DR. HUYSMANS G. - DR. EERDEKENS S. is located at Johannes Stadiuslaan 28, 2990 Wuustwezel.

Is DR. HUYSMANS G. - DR. EERDEKENS S. still active?

Yes. According to the CBE (18 September 2026) DR. HUYSMANS G. - DR. EERDEKENS S. is active, legal situation “Normale toestand”, started on 24 February 2003.

Is DR. HUYSMANS G. - DR. EERDEKENS S. registered on Peppol?

Yes, DR. HUYSMANS G. - DR. EERDEKENS S. is registered on the Peppol network with ID 0208:0479628871.

What is the enterprise number of DR. HUYSMANS G. - DR. EERDEKENS S.?

The enterprise number of DR. HUYSMANS G. - DR. EERDEKENS S. is BE0479628871.

When was DR. HUYSMANS G. - DR. EERDEKENS S. founded?

DR. HUYSMANS G. - DR. EERDEKENS S. was founded on 24 February 2003.

Who are the directors of DR. HUYSMANS G. - DR. EERDEKENS S.?

According to the 2025 annual accounts, the directors of DR. HUYSMANS G. - DR. EERDEKENS S. are: Gert Huysmans, Sonja Eerdekens.

Is DR. HUYSMANS G. - DR. EERDEKENS S. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 February 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. HUYSMANS G. - DR. EERDEKENS S. make in 2025?

DR. HUYSMANS G. - DR. EERDEKENS S. posted a profit after taxes of € 219,490 in financial year 2025.

What is the revenue of DR. HUYSMANS G. - DR. EERDEKENS S.?

As a small company, DR. HUYSMANS G. - DR. EERDEKENS S. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 318,809.

DR. HUYSMANS G. - DR. EERDEKENS S. (Private Limited)

Dossier DR. HUYSMANS G. - DR. EERDEKENS S., printed on 18 September 2026 from databakkes.be/en/0479628871/dr-huysmans-g-dr-eerdekens-s. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. HUYSMANS G. - DR. EERDEKENS S. from Wuustwezel, company number BE0479628871, closed financial year 2025 with a result of € 219,490 after tax. For that financial year DR. HUYSMANS G. - DR. EERDEKENS S. recorded a gross margin of € 318,809 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 200,408 to € 219,490. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 1.4 million

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 219,490

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 428,309

▲ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 315,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 9,798

▼ 61% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,014

▼ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 30,784

▲ 36% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 178,099 Gross margin 2022: € 178,099 First fiscal year in the series	€ 273,864 Gross margin 2023: € 273,864 ▲ 54% vs 2022 (€ 178,099) Favourable step	€ 292,009 Gross margin 2024: € 292,009 ▲ 7% vs 2023 (€ 273,864) Favourable step	€ 318,809 Gross margin 2025: € 318,809 ▲ 9% vs 2024 (€ 292,009) Favourable step	▲ 9%
Profit after taxes	€ 112,059 Profit after taxes 2022: € 112,059 First fiscal year in the series	€ 175,292 Profit after taxes 2023: € 175,292 ▲ 56% vs 2022 (€ 112,059) Favourable step	€ 200,408 Profit after taxes 2024: € 200,408 ▲ 14% vs 2023 (€ 175,292) Favourable step	€ 219,490 Profit after taxes 2025: € 219,490 ▲ 10% vs 2024 (€ 200,408) Favourable step	▲ 10%
Equity	€ 1,078,059 Equity 2022: € 1,078,059 First fiscal year in the series	€ 1,253,351 Equity 2023: € 1,253,351 ▲ 16% vs 2022 (€ 1,078,059) Favourable step	€ 1,453,760 Equity 2024: € 1,453,760 ▲ 16% vs 2023 (€ 1,253,351) Favourable step	€ 1,358,250 Equity 2025: € 1,358,250 ▼ 7% vs 2024 (€ 1,453,760) Unfavourable step	▼ 7%
Total debts	€ 140,642 Total debts 2022: € 140,642 First fiscal year in the series	€ 72,250 Total debts 2023: € 72,250 ▼ 49% vs 2022 (€ 140,642) Favourable step	€ 28,547 Total debts 2024: € 28,547 ▼ 60% vs 2023 (€ 72,250) Favourable step	€ 347,798 Total debts 2025: € 347,798 ▲ € 319,250 vs 2024 (€ 28,547) Unfavourable step	▲ € 319,250
Cash	€ 285,947 Cash 2022: € 285,947 First fiscal year in the series	€ 125,281 Cash 2023: € 125,281 ▼ 56% vs 2022 (€ 285,947) Unfavourable step	€ 318,682 Cash 2024: € 318,682 ▲ 154% vs 2023 (€ 125,281) Favourable step	€ 428,309 Cash 2025: € 428,309 ▲ 34% vs 2024 (€ 318,682) Favourable step	▲ 34%
Retained profit	€ 1,078,059 Retained profit 2022: € 1,078,059 First fiscal year in the series	€ 1,253,351 Retained profit 2023: € 1,253,351 ▲ 16% vs 2022 (€ 1,078,059) Favourable step	€ 1,453,760 Retained profit 2024: € 1,453,760 ▲ 16% vs 2023 (€ 1,253,351) Favourable step	€ 1,358,250 Retained profit 2025: € 1,358,250 ▼ 7% vs 2024 (€ 1,453,760) Unfavourable step	▼ 7%
Dividend	€ 221,368 Dividend 2022: € 221,368 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 221,368) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 315,000 Dividend 2025: € 315,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,218,702 Balance sheet total 2022: € 1,218,702 First fiscal year in the series	€ 1,325,601 Balance sheet total 2023: € 1,325,601 ▲ 9% vs 2022 (€ 1,218,702) Unchanged	€ 1,482,307 Balance sheet total 2024: € 1,482,307 ▲ 12% vs 2023 (€ 1,325,601) Unchanged	€ 1,706,047 Balance sheet total 2025: € 1,706,047 ▲ 15% vs 2024 (€ 1,482,307) Unchanged	▲ 15%

Key figures of DR. HUYSMANS G. - DR. EERDEKENS S., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. HUYSMANS G. - DR. EERDEKENS S.?

What happened at DR. HUYSMANS G. - DR. EERDEKENS S. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 219,490 (▲ 10% vs 2024). filed late Source: NBB ↗
2021 Gert Huysmans became a director. NBB
2021 Sonja Eerdekens became a director. NBB
Feb 24, 2003 Start of the company according to the CBE. KBO
Feb 18, 2003 New establishment in Wuustwezel. KBO

In short

From € 112,059 profit in 2022 to € 219,490 profit in 2025.

Paid € 312,018 in corporate taxes since 2022.

Best year ever: 2025, with € 219,490 profit.

Paid out € 536,368 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. HUYSMANS G. - DR. EERDEKENS S.? We notify you, reason included.

Follow DR. HUYSMANS G. - DR. EERDEKENS S.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gert Huysmans Sonja Eerdekens

DR. HUYSMANS G. - DR. EERDEKENS S.

Behind DR. HUYSMANS G. - DR. EERDEKENS S. are Gert Huysmans and Sonja Eerdekens.

See the full network in the app

Directors

According to the 2025 annual accounts

Gert Huysmans

Director

since 2021

Sonja Eerdekens

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Johannes Stadiuslaan 28

2990 Wuustwezel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.628.871
VAT number: BE 0479.628.871
Registered office: Johannes Stadiuslaan 28, 2990 Wuustwezel
Names & denominations: DR. HUYSMANS G. - DR. EERDEKENS S.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 February 2003
Peppol: Active · Active since 3 Apr 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗